Apraxia Market Research Report- Global Forecast till 2023

Apraxia Market Research Report- Global Forecast till 2023

ID: MRFR/HC/3444-HCRR | | Region: Global | 115 pages | Half-Cooked Research Reports

Apraxia Market Information: By Type (Ideomotor Apraxia, Ideational/Conceptual Apraxia), By Diagnosis (Test To Measure Upper Limb Apraxia, MRI), Treatment (Speech Therapy), End User (Hospitals & Clinics, Research Centers) - Global Forecast Till 2023 


Market Scenario


Apraxia is a neurological condition. Also, it is known as a motor disorder caused by damage to the brain. In this case, patients who find it difficult or impossible to make certain motor movements, even though their muscles are normal. Apraxia can occur in different forms one of which is orofacial apraxia. In which, patients are unable to voluntarily perform certain movements involving facial muscles. For instance, they may not be able to wink. Another form of apraxia affects a patient’s ability to intentionally move arms and legs.


Whereas in children apraxia of speech (CAS) has a number of possible causes, but in many cases, the cause can't be determined and often don't observe a problem in the brain of a child with CAS. CAS may be the result of brain (neurological) conditions or injuries, such as a stroke, infections or traumatic brain injury.


The apraxia market growth is majorly attributed to the increasing prevalence of neurological disorders, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of various neurological diseases are likely to fuel the market growth during the forecast period.


According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


However, the high cost of this treatment procedure may hamper the market growth during the corresponding period.


The global apraxia market is expected to grow at a CAGR of ~ 6.4 % during the forecast period 2017-2023. 


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers

  • Potential Investors 


 Figure: Global Apraxia Market, By Region Market Share, 2016 (%)

Apraxia Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations
The global apraxia market has been segmented on the basis of types, diagnosis, treatment, and end user.


On the basis of the types, the market is segmented into ideomotor apraxia, ideational/conceptual apraxia, buccofacial or orofacial apraxia, constructional apraxia, gait apraxia, limb-kinetic apraxia, oculomotor apraxia, apraxia of speech.


On the basis of the diagnosis, the market is segmented into a test to measure upper limb apraxia, MRI, and others.


On the basis of the treatment, the market is segmented into speech therapy, occupational therapy, physical therapy, and others.


On the basis of the ‘end user, the market is segmented into hospitals & clinics, research centers, and others. 


Regional Analysis
The Americas dominate the global apraxia market owing to well-developed technology, increasing prevalence of neurological disorders, high health care spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.


Europe holds the second position in the global apraxia market. The government support for research & development and availability of funds for research are projected to drive the market in Europe region over the review period.  


Asia Pacific is the fastest growing apraxia market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries like China, India, Japan, and South Korea will make this as emerging and the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is likely to lead the use of advanced equipment, which, in turn, will increase the growth of the market in the region.


On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.


Key Players
Some of key the players in the market are Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, Spiegelberg GmbH, Johnson & Johnson, Sophysa Ltd, HaiWeiKang, Head Sense Medical, InfraScan, Inc., Integra Life Sciences Corporation and others. 


Research Methodology


Global Apraxia Market


Sources: Annual reports, Press release, White paper, and Company presentation

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Apraxia Market, by Type

6.1 Introduction

6.2 Ideomotor Apraxia

Market Estimates & Forecast, 2017-2023

6.3 Ideational/Conceptual apraxia

Market Estimates & Forecast, 2017-2023

6.4 Buccofacial or Orofacial Apraxia

Market Estimates & Forecast, 2017-2023

6.5 Constructional Apraxia

Market Estimates & Forecast, 2017-2023

6.6 Gait Apraxia

Market Estimates & Forecast, 2017-2023

6.7 Limb-kinetic Apraxia

Market Estimates & Forecast, 2017-2023

6.8 Apraxia of Speech

Market Estimates & Forecast, 2017-2023

7. Global Apraxia Market, by Diagnosis

7.1 Introduction

7.2 Test to Measure Upper Limb Apraxia

Market Estimates & Forecast, 2017-2023

7.3 MRI

Market Estimates & Forecast, 2017-2023

7.4 Others

Market Estimates & Forecast, 2017-2023

8. Global Apraxia Market, by Treatment

8.1 Introduction

8.2 Speech Therapy

Market Estimates & Forecast, 2017-2023

8.3 Occupational Therapy

Market Estimates & Forecast, 2017-2023

8.4 Physical Therapy

Market Estimates & Forecast, 2017-2023

9. Global Apraxia Market, by End User

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 2017-2023

9.3 Research Centers

Market Estimates & Forecast, 2017-2023

9.4 Others

Market Estimates & Forecast, 2017-2023

10. Global Apraxia Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Medtronic Plc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Codman & Shurtleff, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Raumedic AG

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Spiegelberg GmbH

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Vittamed, Sophysa Ltd

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 MicroPort Scientific Corporation

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Orsan Medical Technologies

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix



LIST OF TABLES

Table 1 Apraxia Industry Synopsis, 2017-2023

Table 2 Global Apraxia Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3 Global Apraxia Market by Region, 2017-2023, (USD Million)

Table 4 Global Apraxia Market by Types, 2017-2023, (USD Million)

Table 5 Global Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 6 Global Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 7 Global Apraxia Market by End Users, 2017-2023, (USD Million)

Table 8 North America Apraxia Market by Types, 2017-2023, (USD Million)

Table 9 North America Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 10 North America Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 11 North America Apraxia Market by End Users, 2017-2023, (USD Million)

Table 12 US Apraxia Market by Types, 2017-2023, (USD Million)

Table 13 US Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 14 US Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 15 US Apraxia Market by End Users, 2017-2023, (USD Million)

Table 16 Canada Apraxia Market by Types, 2017-2023, (USD Million)

Table 17 Canada Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 18 Canada Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 19 Canada Apraxia Market by End Users, 2017-2023, (USD Million)

Table 20 South America Apraxia Market by Types, 2017-2023, (USD Million)

Table 21 South America Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 22 South America Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 23 South America Apraxia Market by End Users, 2017-2023, (USD Million)

Table 24 Europe Apraxia Market by Types, 2017-2023, (USD Million)

Table 25 Europe Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 26 Europe Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 27 Europe Apraxia Market by End Users, 2017-2023, (USD Million)

Table 28 Western Europe Apraxia Market by Types, 2017-2023, (USD Million)

Table 29 Western Europe Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 30 Western Europe Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 31 Western Europe Apraxia Market by End Users, 2017-2023, (USD Million)

Table 32 Eastern Europe Apraxia Market by Types, 2017-2023, (USD Million)

Table 33 Eastern Europe Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 34 Eastern Europe Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 35 Eastern Europe Apraxia Market by End Users, 2017-2023, (USD Million)

Table 36 Asia Pacific Apraxia Market by Types, 2017-2023, (USD Million)

Table 37 Asia Pacific Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 38 Asia Pacific Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 39 Asia Pacific Apraxia Market by End Users, 2017-2023, (USD Million)

Table 40 Middle East & Africa Apraxia Market by Types, 2017-2023, (USD Million)

Table 41 Middle East & Africa Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 42 Middle East & Africa Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 43 Middle East & Africa Apraxia Market by End Users, 2017-2023, (USD Million)





LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Apraxia Market

Figure 3 Segmentation Market Dynamics for Apraxia Market

Figure 4 Global Apraxia Market Share, by Diagnosis 2016

Figure 5 Global Apraxia Market Share, by Treatment 2016

Figure 6 Global Apraxia Market Share, by End Users, 2016

Figure 7 Global Apraxia Market Share, by Region, 2016

Figure 8 North America Apraxia Market Share, by Country, 2016

Figure 9 Europe Apraxia Market Share, by Country, 2016

Figure 10 Asia Pacific Apraxia Market Share, by Country, 2016

Figure 11 Middle East & Africa Apraxia Market Share, by Country, 2016

Figure 12 Global Apraxia Market: Company Share Analysis, 2016 (%)

Figure 13 Medtronic Plc: Key Financials

Figure 14 Medtronic Plc: Segmental Revenue

Figure 16 Medtronic Plc: Geographical Revenue

Figure 17 Codman & Shurtleff, Inc: Key Financials

Figure 18 Codman & Shurtleff, Inc: Segmental Revenue

Figure 19 Codman & Shurtleff, Inc: Geographical Revenue

Figure 20 Raumedic AG: Key Financials

Figure 21 Raumedic AG: Segmental Revenue

Figure 22 Raumedic AG: Geographical Revenue

Figure 23 Vittamed, Sophysa Ltd: Key Financials

Figure 24 Vittamed, Sophysa Ltd: Segmental Revenue

Figure 25 Vittamed, Sophysa Ltd: Geographical Revenue

Figure 26 Spiegelberg GmbH: Key Financials

Figure 27 Spiegelberg GmbH: Segmental Revenue

Figure 28 Spiegelberg GmbH: Geographical Revenue

Figure 29 MicroPort Scientific Corporation: Key Financials

Figure 30 MicroPort Scientific Corporation: Segmental Revenue

Figure 31 MicroPort Scientific Corporation: Geographical Revenue

Figure 32 Orsan Medical Technologies: Key Financials

Figure 33 Orsan Medical Technologies: Segmental Revenue

Figure 34 Orsan Medical Technologies: Geographical Revenue